We’re working with EndLyz Therapeutics to fund the development of 2 potential drugs that could clear cells of unwanted materials that contribute to the causes of Parkinson’s.
Ahead of World Parkinson’s Day (WPD), members of the community spoke to over 30 MPs and peers in Westminster.
A study, part-funded by Parkinson’s UK, has uncovered important insights into why some people with Parkinson’s develop dementia, while others don’t.
New research shows changes to microbes in the gut can be detected before Parkinson’s symptoms appear.
Parkinson's UK and British Cycling have announced a new physical activity partnership for 2026.
Here are the latest medication supply issues we are aware of.
Parkinson's UK and Komoot announce a new physical activity partnership for 2026.
The therapy has been given conditional, limited approval for people in Japan based on the results of a 2-year research study.
Parkinson's UK has launched a new podcast series to help more people get moving in 2026.
We've been recognised for addressing a recurring patient safety issue, and supporting the NHS to make improvements across the system.
The Department for Work and Pensions (DWP) is making changes to Universal Credit (UC) and Personal Independence Payment (PIP) from 7 April 2026.
A summary of how assisted dying legislation is progressing in Westminster, the Scottish Parliament, the Isle of Man and Jersey, and what happens next.
A £1.7 million partnership will combine data from over 20,000 people to accelerate the search for new treatments for Parkinson’s.
This International Women’s Day, we're celebrating 3 remarkable women making a real difference for people with Parkinson’s. Reflecting the theme Give to Gain, their leadership, skills and passion help the Parkinson’s community thrive.
We've reopened our Physical Activity Grants programme for the 6th successive year to help more people to live well with the condition.
Our UK Parkinson's Audit is the recognised UK-wide audit and quality improvement tool for Parkinson's services.
We're supporting a new dance tutorial from the English National Ballet. It aims to encourage people with Parkinson's to try dancing.
Herantis Pharma Plc to receive almost £7 million from the European Union for a phase 2 trial of HER-096 that has the potential to slow or stop Parkinson’s.